Market outlook: Lofty valuations call for careful stock-picking

Given general valuation levels, careful individual stock selection is more important now.

Elizabeth Collins 30 March, 2017 | 5:00PM
  • The Morningstar Global Markets Index has returned more than 6% year to date and 16% over the past year.
  • The market-cap-weighted price/fair value estimate ratio for our equity analysts' coverage universe is 1.06.
  • Healthcare is the most undervalued sector, with a price/fair value estimate ratio of 0.98. Basic materials is the most overvalued sector, with a price/fair value estimate ratio of 1.44.


Healthcare is top of mind as one of our most undervalued sectors -- if only on a relative basis -- and the one facing the most immediate possible changes under the Trump administration and Republican-controlled Congress in the United States. Both are looking to fulfill the long-standing promise of repealing the Affordable Care Act.

The road to repeal is rough, as the proposed reform ideas could lead to eliminating coverage for millions of Americans, and Republicans hold only a narrow majority in the Senate. The House vote on the American Health Care Act scheduled for Friday, March 24, was called off for lack of support, making the ultimate outcome even more uncertain, given opposition from both very conservative and moderate members within the Republican party. Most Republican proposals would lead to fewer insured Americans, weaker coverage and higher out-of-pocket costs. Our analysts view the drug industry as best positioned for potential changes, with  Roche (RHHBY) and  Allergan (AGN) trading at attractive valuations.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar Rating
Allergan PLC200.15 USD0.71
Hanesbrands Inc14.49 USD-1.56
Roche Holding AG ADR44.03 USD0.39
Williams-Sonoma Inc73.67 USD-0.63

About Author

Elizabeth Collins

Elizabeth Collins  Elizabeth Collins, CFA, is global head of equity research for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. In this role, she leads the global equity research team, which focuses on providing in-depth, fundamental equity research based on sustainable competitive advantages and long-term valuation analysis. Before assuming her current role in 2018, Collins was director of North American equity research. She joined Morningstar in 2005. She holds an MBA from DePaul University and is coauthor of Why Moats Matter: The Morningstar Approach to Stock Investing, published by John Wiley & Sons in 2014.